The cannabis business offers CFOs a real-time case study in navigating complex regulation and business development. As the industry expands amid shifting federal and state rules, finance leaders can examine how companies adapt their accounting, tax strategy and growth plans. It’s a unique lens for understanding how regulation shapes financial decision-making in emerging markets.
An article from
The regulatory and tax challenges of cannabis in 2025
This multi-part series offers finance leaders insight into the state of cannabis finance and the regulatory hurdles that continue to complicate its accounting practices.
-
The cost-benefit of rescheduling cannabis
By Adam Zaki • April 18, 2025Cannabis accountants say rescheduling will remove the accounting headache of 280E, but cannabis attorneys say the move creates a litigious opportunity for Big Pharma to step in. Read the full article ➔
-
Why intoxicating hemp is a growing threat to regulated cannabis businesses
By Adam Zaki • April 18, 2025Though the business around hemp-based cannabis is growing, the lighter regulatory scrutiny of these products is creating challenges for those trying to follow the rules. Read the full article ➔
Filed Under:
Series
